1
TITLE: Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTHORS: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLISHED: 2023
INDEXED IN: CrossRef
IN MY: ORCID
2
TITLE: Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTHORS: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLISHED: 2023
INDEXED IN: CrossRef
IN MY: ORCID
3
TITLE: Data from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTHORS: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLISHED: 2023
INDEXED IN: CrossRef
IN MY: ORCID
4
TITLE: Data from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTHORS: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLISHED: 2023
INDEXED IN: CrossRef
IN MY: ORCID
5
TITLE: Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
AUTHORS: José Á García-Sáenz; Noelia Martínez-Jáñez; Ricardo Cubedo; Yolanda Jerez; Ainhara Lahuerta; Santiago González-Santiago; Nieves Ferrer; Manuel Ramos; Jose L Alonso-Romero; Antonio Antón; Eva Carrasco; Jingjing Chen; Rachel Neuwirth; Kevin Galinsky; Sylvie Vincent; Jane J Leonard; Dennis Slamon;
PUBLISHED: 2022, SOURCE: Clinical Cancer Research, VOLUME: 28, ISSUE: 6
INDEXED IN: CrossRef: 9
IN MY: ORCID
6
TITLE: Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study
AUTHORS: Virginia Lope; Angel Guerrero-Zotano; Emma Ruiz-Moreno; Begoña Bermejo; Silvia Antolín; Álvaro Montaño; José Manuel Baena-Cañada; Manuel Ramos Vázquez; Nerea Fernández de Larrea-Baz; José Ignacio Chacón; José Angel García-Sáenz; Clara Olier; Montserrat Muñoz; Antonio Antón; Pedro Sánchez Rovira; Angels Arcusa Lanza; Sonia González; Amparo Oltra; Joan Brunet; Joaquín Gavilá Gregori; María Teresa Martínez; Lourdes Calvo; Libertad Rosell; Susana Bezares; Roberto Pastor-Barriuso; Beatriz Pérez-Gómez; Miguel Martín; Marina Pollán; ...More
PUBLISHED: 2022, SOURCE: Cancers, VOLUME: 14, ISSUE: 19
INDEXED IN: CrossRef: 3
IN MY: ORCID